Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Capital Employed (2018 - 2025)

Arcus Biosciences has reported Return on Capital Employed over the past 8 years, most recently at 0.47% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.47% for Q4 2025, down 14.0% from a year ago — trailing twelve months through Dec 2025 was 0.47% (down 14.0% YoY), and the annual figure for FY2025 was 0.42%, down 5.0%.
  • Return on Capital Employed for Q4 2025 was 0.47% at Arcus Biosciences, up from 0.47% in the prior quarter.
  • Over the last five years, Return on Capital Employed for RCUS hit a ceiling of 0.06% in Q3 2022 and a floor of 0.47% in Q3 2025.
  • Median Return on Capital Employed over the past 5 years was 0.29% (2023), compared with a mean of 0.26%.
  • Biggest five-year swings in Return on Capital Employed: soared 44bps in 2022 and later plummeted -38bps in 2023.
  • Arcus Biosciences' Return on Capital Employed stood at 0.05% in 2021, then tumbled by -572bps to 0.24% in 2022, then tumbled by -46bps to 0.35% in 2023, then grew by 7bps to 0.33% in 2024, then crashed by -42bps to 0.47% in 2025.
  • The last three reported values for Return on Capital Employed were 0.47% (Q4 2025), 0.47% (Q3 2025), and 0.37% (Q2 2025) per Business Quant data.